Comprehensive Care for Persons with Diabetes: A Certificate Program
Image For Activity Cover
14 Courses
Expires 365 days after start
Member: $450.00
Non-Member: $550.00
In-Training Member: $350.00
Resident Member: $350.00
Resident Non-Member: $550.00
Credit Offered
15 AMA PRA Category 1 Credits
15 ABIM-MOC Points
15 Participation Credits
  • Course Description
  • Learning Objectives
  • Target Audience
  • Full Program
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended

Endocrine Society, in collaboration with the American College of Osteopathic Family Physicians (ACOFP), has created a certificate program exploring the many facets of diabetes care and management. Developed through the efforts of endocrinologists and family physicians, this 12-part course encompasses both the clinical aspects of diabetes care as well as the supportive social pieces.  

This course features 12 modules, each with a pre- and post-test, as well as a final exam to test your knowledge and competency at the end of the course. The entire course, including the final exam, has 15.00 AMA PRA Category 1 credits, 15.00 ABIM MOC points, and 15.00 AOA Category 1-A CME available. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam. 

Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024.

Upon the successful completion of this 12-part course, learners will:  

  • Describe the spectrum of diabetes and considerations in special populations to provide personalized care.  

  • Identify patient-centered approaches to support psychosocial concerns and social determinants of health in patients with diabetes.  

  • Recognize approaches to patient engagement for successful approaches to prevention of progression of prediabetes to type 2 diabetes.  

  • Apply medical therapy options of insulin and non-insulin treatments to managing patient cases.  

  • Compare innovative approaches to care delivery with new technology and therapeutic options. 

The certificate program is suitable for all members of the care team, including all post-graduate trainees interested in expanding their approaches to diabetes care and management. This innovative course is designed for those responsible for the care of patients with diabetes, primarily physicians, nurse practitioners, registered nurses, physician assistants, and pharmacists.
This course has been designed in partnership between endocrinologists and family physicians to provide a holistic course on diabetes care and management. Through this 12-part interactive course, you will learn innovative approaches to caring for persons with diabetes and improving their outcomes and quality of life. 



Differentiating the Spectrum of Diabetes  

Kim M. Pfotenhauer, DO 

Prediabetes & Successful Approaches to Prevention   

Kevin T. Miller, DO 

Lifestyle Approaches to Type 2 Diabetes  

Elizabeth M. Venditti, PhD 

Social Determinants of Health  

Jay H. Shubrook, DO, FAAFP, FACOFP 

Medical Therapy: Insulin Treatment  

John L. Leahy, MD 

Medical Therapy: Non-Insulin Treatment  

Lawrence Blonde, MD, FACP, MACE 

Maximizing Patient Engagement  

Eden M. Miller, DO 

Diabetes Technology and Therapeutics  

Anne L. Peters, MD 

Innovative Approaches to Care Delivery 

Leonard Bertheau, DO 

Management of Complications  

Davida F. Kruger, MSN, APN-BC,BC-ADM 

Diabetes and Psychosocial Concerns  

Robert S. Gotfried, DO, FAAFP 

Considerations in Special Populations  

Mark E. Molitch, MD 

For each module
, you will first complete a short pre-test to gauge your current knowledge and competency levels. Then you will complete an interactive module that should take between 40-60 minutes to finish. Once the module has been completed, you will take a short post-test to indicate the enhancements to your knowledge and competency. 

You will repeat this for all 12 modules. Once you have completed all 12, you will have access to a comprehensive final exam covering content from all 12 modules. You must get a 70% or higher on this exam to obtain your certificate, and you will have 3 attempts. After successfully completing the exam, you will receive your certificate and access to various references and resources. 

The entire course, including the final exam, has 15.00 AMA PRA Category 1 credits, 15.00 ABIM MOC points, and 15.00 AOA Category 1-A CME points available. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Endocrine Society and the American College of Osteopathic Family Physicians. The Endocrine Society is accredited by the ACCME to provide continuing medical education for physicians.  

 AMA PRA Category 1 Credit

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.  

The Endocrine Society designates this course for a maximum of 15.00 AMA PRA Category 1Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field. 
Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body. 

Maintenance of Certification (MOC) - if eligible 

Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 15.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

For questions about content or obtaining CME credit, please contact the Endocrine Society at

AOA Category 1-A Credit
The American College of Osteopathic Family Physicians (ACOFP) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOFP designates this program for a maximum number of 15.00 AOA Category 1-A credits and will report CME with the extent of the physician’s participation in this activity. This program is sponsored by ACOFP for educational purposes only. 

Kim Pfotenhauer, DO
Michigan State University College of Osteopathic Medicine
East Lansing, MI

Kevin T. Miller, DO
Diabetes and Obesity Care
Bend, OR 

Elizabeth M. Venditti, PhD
University of Pittsburgh School of Medicine
Pittsburgh, PA 

Jay H. Shubrook, DO, FAAFP, FACOFP
Touro University
Vallejo, CA 

John L. Leahy, MD
University of Vermont
Burlington, VT 

Lawrence Blonde, MD, FACP, MACE
Ochsner Medical Center
New Orleans, LA 

Eden M. Miller, DO
Diabetes and Obesity Care
Bend, OR 

Anne L. Peters, MD
University of Southern California
Los Angeles, CA 

Leonard R. Bertheau, DO
Adventist Health
Portland, OR 

Davida F. Kruger, MSN, APN-BC,BC-ADM
Henry Ford Health System
Detroit, MI 

Robert S. Gotfried, DO, FAAFP
Ohio State University Wexner Medical Center
Columbus, OH 

Mark E. Molitch, MD
Northwestern University Feinberg School of Medicine
Chicago, IL 

Statement of Independence 
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force. 

This program is sponsored by ACOFP for educational purposes only. The material presented is not intended to represent the sole or best medical interventions for the discussed diagnoses, but rather is intended to present the opinions of the authors or presenters that may be helpful to other practitioners. Attendees participating in this medical education program do so with the full knowledge that they waive any claim they may have against ACOFP for reliance on any information presented during these educational activities. 

The American College of Osteopathic Family Physicians (ACOFP) online education is an educational resource and as such does not define a standard of care, nor is it intended to dictate an exclusive course of treatment or procedure to be followed. It presents methods and techniques of clinical practice that are acceptable and used by recognized authorities, for consideration by licensed physicians and healthcare providers to incorporate into their practice. Variations of practice, taking into account the needs of the individual patient, resources, and limitation unique to the institution or type of practice, may be appropriate. 

The statements and opinions expressed within this educational program are those of the faculty and not necessarily those of the ACOFP. The ACOFP disclaims any responsibility and/or liability for such information. 

Faculty Disclosure Policies
It is the policy of the American College of Osteopathic Family Physicians (ACOFP) to ensure balance, independence, objectivity, and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any ACOFP sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It remains for the audience to determine whether the speaker's outside interests may reflect a possible bias in either the exposition or the conclusions presented. 

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. 

The following faculty reported relevant financial relationships: Kevin T. Miller, DO: Advisory Board - Astra Zeneca; Research Funding - Abbott, Pendulum. Elizabeth M. Venditti, PhD: Advisory Board - PeopleOne Health. Jay H. Shubrook, DO, FAAFP, FACOFP: Advisory Board - Novo Nordisk, Bayer, Eli Lilly. John L. Leahy, MD: Advisory Board - Merck & Co, Hillbloom Foundation. Lawrence Blonde, MD, FACP, MACE: Consultant - Corcept Therapeutics, Gilead Sciences, Janssen Pharmaceuticals, Lyndra Therapeutics, Merck, Novo Nordisk, Salix Pharmaceuticals, Sanofi. Eden M. Miller, DO: Advisory Board - Abbott, Lilly, Novo Nordisk, Boehringer Ingelheim, Merck, Bayer, Pendulum. Anne L. Peters, MD: Advisory Board - Abbott, Astra Zeneca, Lilly, Medscape, Novo Nodisk, Zealand, Vertex. Leonard R. Bertheau, DO: Speaker - Medtronic. Davida F. Kruger, MSN, APN-BC, BC-ADM: Speaker - Novo Nordisk, Eli Lilly, Abbott, Dexcom, Xeris, Astra Zeneca, Sanofi; Advisor - Novo Nordisk, Eli Lilly, Abbott, Sanofi; Stock Options - Pendulum; Research Funding - Novo Nordisk, Dexcom, Abbott. Mark E. Molitch, MD: Research Funding - Bayer, Novartis; Consultant - Janssen, Merck, Pfizer. 

The following faculty reported no relevant financial relationships: Kim Pfotenhauer, DO; Robert S. Gotfried, DO, FAAFP

The Endocrine Society and ACOFP staff associated with the development of this CME activity reported no relevant financial relationships.  

The Endocrine Society and ACOFP staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable. 


This activity is not supported by educational grant(s) or other funds from any commercial supporter. 

     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Android App Download IOS App Download Powered By